RedHill Biopharma Ltd. (RDHL)
6.24
-0.11 (-1.73%)
At close: Jan 28, 2025, 1:19 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| PE Ratio | 9.89 | -3.67 | -26.25 | -82.66 | -103.26 | -81.62 | -49.33 | -110.16 | -169.19 | -269.47 | -173.15 | -107.5 | -66.69 | -444.5 |
| PS Ratio | 36.30 | 3.51 | 34.99 | 114.33 | 716.23 | 378.99 | 560.66 | 32.03K | 1.19M | 411.50 | 153.35K | 69.38K | 44.95K | n/a |
| PB Ratio | 114.28 | -4.49 | 338.14 | 530.75 | 75.09 | 61.90 | 49.85 | 51.60 | 59.39 | 115.40 | 154.31 | 58.37 | 55.03 | n/a |
| P/FCF Ratio | -6.6 | -7.39 | -46.05 | -71.89 | -110.03 | -91.78 | -48.89 | -114.01 | -183.36 | -216.46 | -212.49 | -160.81 | -212.21 | -412.7 |
| P/OCF Ratio | -6.6 | -7.44 | -46.14 | -151.47 | -110.57 | -91.94 | -50.18 | -114.49 | -200.17 | -236.02 | -218.13 | -163.36 | -220.4 | -692.89 |
| OCF/S Ratio | -5.5 | -0.47 | -0.76 | -0.75 | -6.48 | -4.12 | -11.17 | -279.78 | -5.94K | -1.74 | -703 | -424.69 | -203.96 | n/a |
| Debt / Equity Ratio | 0.57 | -2.53 | 9.89 | 6.27 | 0.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 0.61 | 0.38 | 0.91 | 0.87 | 4.84 | 5.40 | 4.31 | 12.45 | 17.23 | 23.87 | 5.37 | 18.10 | 39.43 | n/a |
| Current Ratio | 0.84 | 0.44 | 1.09 | 0.96 | 5.01 | 5.47 | 4.37 | 12.66 | 10.97 | 15.13 | 5.22 | 17.22 | 36.52 | n/a |
| Asset Turnover | 0.28 | 0.39 | 0.47 | 0.36 | 0.08 | 0.13 | 0.07 | 0.00 | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 | n/a |
| Interest Coverage | 34.42 | -1.04 | -4.9 | -4.99 | -98.63 | -235.51 | -674.96 | -81.45 | -103.78 | -27.8 | -769.43 | -6.1 | -121.12 | -1.98 |
| Return on Equity (ROE) | 11.56 | 1.22 | -12.88 | -6.42 | -0.73 | -0.76 | -1.01 | -0.47 | -0.35 | -0.43 | -0.89 | -0.54 | -0.83 | n/a |
| Return on Assets (ROA) | 1.04 | -0.37 | -0.63 | -0.49 | -0.59 | -0.62 | -0.79 | -0.4 | -0.32 | -0.37 | -0.74 | -0.51 | -0.77 | n/a |
| Return on Capital (ROIC) | 3.32 | 1.11 | -0.81 | -0.6 | -0.68 | -0.76 | -1.14 | -0.44 | -0.36 | -0.39 | -0.9 | -0.48 | -0.4 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 46.89% | 46.06% | 42.39% | 42.68% | 64.09% | 66.06% | 46.94% | -30.14K% | -733.30K% | 85.03% | 100.00% | 100.00% | 100.00% | n/a |
| Net Profit Margin | 367.19% | -95.87% | -133.3% | -138.31% | -693.59% | -464.35% | -1.14K% | -29.08K% | -703.00K% | -152.71% | -88.57K% | -64.54K% | -67.40K% | n/a |
| Pretax Profit Margin | 367.75% | -115.97% | -113.98% | -118.36% | -672.45% | -464.35% | -1.14K% | -29.08K% | -703.00K% | -152.71% | -88.57K% | -64.54K% | -67.40K% | n/a |
| Operating Profit Margin | 193.95% | -69.33% | -94.61% | -98.95% | -686.71% | -470.47% | -1.30K% | -30.24K% | -733.40K% | -151.8% | -89.77K% | -56.50K% | -34.23K% | n/a |
| FCF Margin | -550.13% | -47.55% | -75.98% | -159.03% | -650.96% | -412.92% | -1.15K% | -28.10K% | -648.67K% | -190.11% | -72.17K% | -43.14K% | -21.18K% | n/a |
| EBITDA Margin | 403.94% | -69.33% | -73.5% | -85.36% | -648.3% | -461.77% | -1.14K% | -30.20K% | -728.87K% | -151.41% | -89.57K% | -56.35K% | -34.17K% | n/a |